Most people adapt well to this change, though some experience altered fat digestion
8,11 Tirzepatide (Zepbound), a dual GLP-1/GIP RA, received FDA approval in November 2023 for chronic weight management in adults with obesity or overweight who have at least one weight-related comorbidity
It can be hard to tell the difference between a colored mole and an early melanoma lesion
One month or longer Discuss dose, treatment indication, health conditions, other medications, and realistic goals
Understanding your genetic context does not predict exact medication response to colds or interactions with OTC drugs, but it can support a more nuanced conversation with your provider about symptom patterns you might experience during seasonal illness
How to Check Your Insurance Coverage Before Starting Treatment Before committing to any GLP-1 treatment pathway, contact your insurance company's customer service line and provide your member ID